Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Heart Failure
The heart is unable to pump blood in sufficient amounts from the ventricles to meet the bodys metabolic needs Symptoms depend on the cardiac area affected
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Cardiac defect
Supraventricular dysrhythmias
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Increase the force of myocardial contraction Increase heart rate Accelerate cardiac conduction
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
ACE inhibitors Angiotensin II receptor blockers B-type natriuretic peptides Phosphodiesterase inhibitors Cardiac glycosides
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
10
Prevent sodium and water resorption by inhibiting aldosterone secretion Diuresis results, which decreases preload, or the left ventricular end-volume, and the work of the heart Examples: lisinopril, enalapril, captopril, others
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
11
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
12
Potent vasodilators; decrease systemic vascular resistance (afterload) Examples: valsartan, candesartan, losartan
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
13
nesiritide (Natrecor)
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
14
Vasodilating effects on arteries and veins Indirectly increases cardiac output Suppresses renin-angiotensin system Diuresis
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
15
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
16
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
17
Short-term management of heart failure Given when patient does not respond to treatment with digoxin, diuretics, and/or vasodilators AHA and ACC advise against weekly infusions
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
18
inamrinone
Thrombocytopenia, most worrisome Dysrhythmia, nausea, hypotension Elevated liver enzymes with long-term use
milrinone
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
19
Cardiac Glycosides
No longer used as first-line treatment Originally obtained from Digitalis plant, foxglove Digoxin is the prototype Used in heart failure and to control ventricular response to atrial fibrillation or flutter
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
20
Decrease rate of electrical conduction Prolong the refractory period Area between SA node and AV node
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
21
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
22
Increased force and velocity of myocardial contraction (without an increase in oxygen consumption) Reduced heart rate
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
23
Increased stroke volume Reduction in heart size during diastole Decrease in venous BP and vein engorgement Increase in coronary circulation Promotion of diuresis because of improved blood circulation Palliation of exertional and paroxysmal nocturnal dyspnea, cough, and cyanosis
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
24
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
25
digoxin (Lanoxin)
Very narrow therapeutic window Drug levels must be monitored 0.5 to 2 ng/mL Low potassium levels increase its toxicity Electrolyte levels must be monitored
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
26
Cardiovascular Dysrhythmias, including bradycardia or tachycardia CNS Headaches, fatigue, malaise, confusion, convulsions
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
27
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
28
Digoxin Toxicity
Hyperkalemia (serum potassium greater than 5 mEq/L) in a digitalis-toxic patient Life-threatening cardiac dysrhythmias Life-threatening digoxin overdose
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
29
Electrolyte imbalances
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
30
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
31
Weight, I&O measures ECG Serum labs: potassium, sodium, magnesium, calcium, renal, and liver function studies
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
32
Before giving any dose, count apical pulse for 1 full minute For apical pulse less than 60 or greater than 100 beats/minute
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
33
Anorexia, nausea, vomiting, diarrhea Visual disturbances (blurred vision, seeing green or yellow halos around objects)
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
34
Check dosage forms carefully, and follow instructions for giving Avoid giving digoxin with high-fiber foods (fiber binds with digitalis) Patients should immediately report a weight gain of 2 or more pounds in 1 day or 5 or more pounds in 1 week
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
35
Use an infusion pump Monitor I&O, heart rate and rhythm, BP, daily weights, respirations, and so on Do not mix with dextrose Solution color is true yellow
IV inamrinone
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
36
Increased urinary output Decreased edema, shortness of breath, dyspnea, crackles, fatigue Resolution of paroxysmal nocturnal dyspnea Improved peripheral pulses, skin color, temperature
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
37
Critical Thinking
A patient has been receiving digoxin therapy for 2 months. During todays visit, he tells you that he has been seeing yellowish rings around lights and has had no appetite. His latest blood potassium level is 5.6 mEq/L. What is the concern with this patient, and what should be done?
Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
38